share_log

贵州三力(603439.SH)股东国盛海通民企高质量发展基金完成减持9900股 持股比例降至5%以下

Guizhou Sanli Pharmaceutical Co.,Ltd. (603439.SH) shareholder Guosheng Haitong Private Enterprise High-quality Development Fund completed the shareholding of 9900 shares, reducing the shareholding ratio to below 5%.

Zhitong Finance ·  Nov 21, 2024 16:38

Guizhou Sanli Pharmaceutical Co.,Ltd. (603439.SH) announced that the shareholder Shanghai Guosheng Capital Management Co., Ltd. - Shanghai Guosheng Haitong...

According to the report by China Securities and Futures, Guizhou Sanli Pharmaceutical Co.,Ltd. (603439.SH) announced that the shareholder Shanghai Guosheng Capital Management Co., Ltd. - Shanghai Guosheng Haitong Mingqi High-Quality Development Private Equity Investment Fund Partnership Enterprise (Limited Partnership) (referred to as 'Guosheng Haitong Mingqi High-Quality Development Fund') reduced its shareholding by 9,900 shares in the company, and the planned shareholding reduction period has expired.

As of the date of this announcement, the shareholder Guosheng Haitong Mingqi High-Quality Development Fund holds 20.4901 million shares in the company, accounting for 4.999997% of the total share capital of the company. After the shareholding reduction is completed, Guosheng Haitong Mingqi High-Quality Development Fund will no longer be a shareholder holding more than 5% of the company.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment